-
TUNEL Apoptosis Detection Kit for Glioma Studies
2026-08-24
Learn how to apply DAB-based TUNEL staining to cultured glioma cells and tissue sections, connecting DNA fragmentation with treatment response and tissue morphology. The workflow combines practical controls, optimization guidance, and a glioma-focused interpretation framework based on recent network pharmacology and experimental findings.
-
HyperScript™ Reverse Transcriptase for RNA Assays
2026-08-24
Learn how HyperScript™ Reverse Transcriptase can strengthen RNA to cDNA conversion when adipose-tissue transcripts are long, structured, or scarce. This article translates new Netrin-1 biology into practical cDNA synthesis for qPCR and assay-validation decisions.
-
GSK126 and the Next Generation of EZH2 Translation
2026-08-23
A translational framework for using GSK126 to connect PRC2 biology, H3K27me3 pharmacodynamics, cancer epigenetics research, and emerging EZH2 degradation insights.
-
Annexin V-APC/7-AAD Apoptosis Kit Guide
2026-08-22
The Annexin V-APC/7-AAD Apoptosis Kit connects phosphatidylserine exposure with membrane-integrity analysis for rigorous apoptosis and necrosis detection. This guide explains how to interpret the assay alongside mechanistic studies of epigenetic drug response, including MLL-rearranged leukemia research.
-
Rosiglitazone: Designing Better Adipose Assays
2026-08-21
Rosiglitazone and Brl-49653 provide a precise way to interrogate PPARγ biology. This guide develops a comparative assay framework that separates adipogenesis, insulin sensitivity modulation, and beige-fat thermogenesis using recent SEMA3E research.
-
SR 11302: AP-1 Transcription Factor Inhibitor Guide
2026-08-20
SR 11302 enables selective interrogation of AP-1-driven proliferation, tumor promotion, and macrophage-associated cancer biology without activating retinoid receptors. This practical guide connects cell-based dose–response assays with the TLR4–macrophage framework reported in colitis-associated colorectal cancer research.
-
Engineered Klotho mRNA Reverses Senescence in iMSCs
2026-08-20
The reference study combines engineered, non-integrating Klotho mRNA with hyperbranched poly(β-amino ester) delivery to address senescence in Klotho-deficient and aged induced mesenchymal stem cells. Its findings connect restored Klotho expression with improved mitochondrial function, reduced oxidative stress, normalized calcium homeostasis, and selective recovery of older or Klotho-deficient cells.
-
Adipose–Neural Signaling in Cardiac Arrhythmia
2026-08-19
Fan et al. developed a stem cell-based coculture model showing that epicardial adipocyte-derived leptin activates sympathetic neurons, increases neuropeptide Y release, and promotes cardiomyocyte arrhythmia through Y1R, NCX, and CaMKII signaling. Patient observations linking greater epicardial adipose tissue thickness with higher leptin and NPY levels support the model’s clinical relevance and identify experimentally testable intervention points.
-
BET Inhibition in HPV-16-Associated HNSCC
2026-08-19
This preprint shows that BET inhibition suppresses HPV transcription and cellular oncogenic programs in HPV-16-associated head and neck squamous cell carcinoma, but that the response is heterogeneous across models. Its combination of TCGA analysis, pharmacologic perturbation, and BRD4 knockdown supports a context-dependent view of viral–host transcriptional regulation and informs interpretation of BRD4-dependent cell line studies.
-
Angiotensin III: From RAAS Biology to Assay Design
2026-08-18
Angiotensin III is more than a downstream RAAS metabolite: its sequence, receptor profile, and assay context determine how biological responses should be interpreted. This guide connects A1043 characterization with the 2025 spike–receptor binding study to support better cardiovascular, neuroendocrine, and biochemical assay design.
-
PKH26 Red Fluorescent Cell Linker Kit Guide
2026-08-18
The PKH26 Red Fluorescent Cell Linker Kit provides membrane lipid-region labeling for longitudinal cell tracing and proliferation-oriented assays. It is intended for intact-cell membrane applications in vitro and in vivo, not for intracellular targets or non-membrane-specific labeling.
-
ERK Links IFNγ Signaling to Melanoma Cell Death
2026-08-17
Champhekar et al. identify ERK as a central mediator of interferon-gamma-induced melanoma cell death, connecting cytokine signaling to a stress response involving DR5 and NOXA. Their complementary chemical-genetic, CRISPR, transcriptomic, imaging, and apoptosis assays provide a framework for studying why melanoma cells differ in sensitivity to immune-mediated growth inhibition.
-
TNF-alpha Recombinant Murine Protein in Apoptosis
2026-08-17
Use TNF-alpha recombinant murine protein as a controlled apoptosis and inflammation stimulus, then compare its receptor-driven effects with RNA Pol II degradation-dependent cell death. This workflow emphasizes dose planning, orthogonal readouts, protein handling, and controls that prevent cytokine activity from being confused with transcriptional stress.
-
GLT-1, CB1-CREB, and TBI Cognitive Dysfunction
2026-08-16
A 2025 Biomolecules study identifies a mechanistic link between post-traumatic 2-AG elevation, CB1-CREB signaling, reduced astrocytic GLT-1, and neuronal excitotoxicity. In mice, CB1 blockade restored GLT-1 expression, reduced neuronal apoptosis, and improved behavioral measures of cognitive dysfunction after traumatic brain injury.
-
Dasatinib Monohydrate in Tumor–Stroma Assays
2026-08-15
Dasatinib Monohydrate is a powerful probe for studying kinase-dependent signaling in heterogeneous tumor models. This article explains how matched gastric cancer assembloids can distinguish tumor-intrinsic drug activity from stromal modulation, while preserving the compound’s relevance to imatinib-resistant BCR-ABL inhibition.